任意団体JBCRG論文・出版
術前化学療法を施行したホルモンレセプター陽性乳癌におけるリンパ節転移の予後因子としての意義-JBCRG-01・JBCRG-02・JBCRG-03のプール化解析-
黒井克昌、戸井雅和、大野真司、中村清吾、岩田広治、増田慎三、佐藤信昭、津田 均、黒住昌史、秋山 太
乳癌の臨床Vol.31 No.5, p413-422 2016
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim, Yasuhiro Yanagita, Shinji Ohno, Shintaro Takao, Kenjiro Aogi, Hiroji Iwata, Joon Jeong, Aeree Kim, Kyong-Hwa Park, Hironobu Sasano, Yasuo Ohashi, and Masakazu Toi.
The New England Journal oｆ Medicine 2017; 376:2147-2159 June 1, 2017DOI: 10.1056/NEJMoa1612645
Prognostic significance of subtype and pathologic response in operable breast cancer: a pooled analysis of prospective neoadjuvant studies of JBCRG
Kuroi K, Toi M, Ohno S, Nakamura S, Iwata H, Masuda N, Sato N, Tsuda H, Kurosumi M, Akiyama F.
Breast Cancer (2015) 22:486-495
Comparison of different definitions of pathologic complete response in operable breast cancer; a pooled analysis of three prospective neoadjuvant studies of JBCRG
Kuroi K, Toi M, Ohno S, Nakamura S, Iwata H, Masuda N, Sato N, Tsuda H, Kurosumi M, Akiyama F.
Breast Cancer 2015 Nov;22(6):586-95.
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer.
Kuroi K,. Toi M, Tsuda H, Kurosumi M, Akiyama F; Japan Breast Cancer Research Group (JBCRG).
Biomed Pharmacother. 2005 Oct;59 Suppl 2:S387-92.
病理学的完全奏効ypT0/isypN0の臨床的意義 ‐JBCRG-01，JBCRG-02，JBCRG-03のプール化解析-
黒井克昌、戸井雅和、大野真司、中村清吾、岩田広治、増田慎三、佐藤信昭、津田 均、黒住昌史、秋山 太
乳癌の臨床 Vol.28 No.6 2013
Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients With Primary Breast Cancer
岩田広治、佐藤信昭、増田慎三、中村清吾、山本尚人、黒井克昌、黒住昌史、津田 均、秋山 太、大橋靖雄、戸井雅和
Japanese Journal of Clinical Oncology 41: 867-875, 2011
CREATE-X (JBCRG-04) 試験.
増田慎三
Cancer Board乳癌 2(1) 70, 2009.
PhaseII study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival
Toi M, Nakamura S, Kuroi K, Iwata H, Ohno S, Masuda N, Kusama M, YamazakiK, Hisamatsu K, Sato Y, Kashiwaba M, Kaise H, Kurosumi M, Tsuda H, Akiyama F,Ohashi Y, Takatsuka Y; for Japan Breast Cancer Research Group (JBCRG)
Breast Cancer Res Treat. 2008 Aug;110(3):531-9. Epub 2007 Sep 19
原発乳癌に対するFEC followed by docetaxel 100mg/m2併用療法による術前化学療法の検討 -JBCRG02-
中村 清吾、増田 慎三、岩田 広治、戸井 雅和、黒井 克昌、黒住 昌史、津田 均、秋山 太; Japan Breast Cancer Research Group (JBCRG).
乳癌の臨床 23(2):111-117, 2008